An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Continuous cultures of fused cells secreting antibody of predefined specificity

Köhler, G., & Milstein, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,200 · see citing works

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574 · see citing works

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,345 · see citing works

Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche

Kärber, G. (1931) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01863914 · Cited by 3,074 · see citing works

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,631 · see citing works

Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries

Jostock, T., Vanhove, M., Brepoels, E., van Gool, R., Daukandt, M., Wehnert, A., van Hegelsom, R., Dransfield, D., Sexton, D., Devlin, M., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.03.014 · Cited by 2,562 · see citing works

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477 · see citing works

Phage antibodies: filamentous phage displaying antibody variable domains

McCafferty, J., Griffiths, A. D., Winter, G. P., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,427 · see citing works

Antigen-specific interaction between T and B cells

Lanzavecchia, A. (1985) · Nature · doi:10.1038/314537a0 · Cited by 1,416 · see citing works

Replacing the complementarity-determining regions in a human antibody with those from a mouse

Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406 · see citing works

Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells

Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304 · see citing works

Identification of Severe Acute Respiratory Syndrome in Canada

Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D. E., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,130 · see citing works

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

Donnelly, C. A., Ghani, A. C., Leung, G. M., Hedley, A. J., Fraser, C., Riley, S., Abu-Raddad, L. J., Ho, L.-M., Thach, T.-Q., Chau, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13410-1 · Cited by 940 · see citing works

Koch's postulates fulfilled for SARS virus

Fouchier, R. A. M., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J. J., van den Hoogen, B. G., Peiris, M. J. S., Lim, W. W. L., Stöhr, K., & Osterhaus, A. D. M. E. (2003) · Nature · doi:10.1038/423240a · Cited by 790 · see citing works

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

Johnson, S., Oliver, C. N., Prince, G. A., Hemming, V. G., Pfarr, D. S., Wang, S., Dormitzer, M., O'Grady, J., Koenig, S., Tamura, J. K., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514115 · Cited by 642 · see citing works

Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells

Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605 · see citing works

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

Brekke, O. H., & Sandlie, I. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd984 · Cited by 552 · see citing works

Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice

Subbarao, K., McAuliffe, J. M., Vogel, L., Fahle, G. A., Fischer, S. H., Tatti, K. M., Packard, M. M., Shieh, W., Zaki, S. R., & Murphy, B. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 397 · see citing works

Primary respiratory syncytial virus infection in mice

Graham, B. S., Perkins, M. D., Wright, P. F., & Karzon, D. T. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890260207 · Cited by 393 · see citing works

EB virus-induced B lymphocyte cell lines producing specific antibody

Steinitz, M. O., Klein, G., KOSKIMIES, S., & MAKEL, O. (1977) · Nature · doi:10.1038/269420a0 · Cited by 392 · see citing works

Passive immunity in prevention and treatment of infectious diseases

Keller, M. A., & Stiehm, E. R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.602 · Cited by 388 · see citing works

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

Green, L. L. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00137-4 · Cited by 229 · see citing works

An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector

Perri, S., Greer, C. E., Thudium, K., Doe, B., Legg, H., Liu, H., Romero, R. E., Tang, Z., Bin, Q., Dubensky, T. W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10394-10403.2003 · Cited by 172 · see citing works

Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique.

Kozbor, D., & Roder, J. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.4.1275 · Cited by 156 · see citing works

Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein

Gebauer, F., Posthumus, W. P. A., Correa, I., Sae, C., Smerdou, C., Sánchez, C. M., Lenstra, J. A., Meloen, R. H., & Enjuanes, L. (1991) · Virology · doi:10.1016/0042-6822(91)90135-x · Cited by 130 · see citing works

κ+λ+ dual receptor B cells are present in the human peripheral repertoire.

Giachino, C., Padovan, E., & Lanzavecchia, A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1245 · Cited by 113 · see citing works

[On the development of immunity to diphtheria and tetanus in animals].

Behring, & Kitasato (1965) · PubMed · Cited by 113 · see citing works

A human myeloma cell line suitable for the generation of human monoclonal antibodies

Karpas, A., Dremucheva, A., & Czepulkowski, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1799 · Cited by 71 · see citing works

Human Anti-Tetanus Toxoid Monoclonal Antibody Secreted by EBV-Transformed Human B Cells Fused with Murine Myeloma

Kozbor, D., Roder, J., CHANG, T. H., Steplewski, Z., & Koprowski, H. (1982) · Hybridoma · doi:10.1089/hyb.1.1982.1.323 · Cited by 71 · see citing works

Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

Becker, S., Feldmann, H., Will, C., & Slenczka, W. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00193395 · Cited by 63 · see citing works

Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model

Stack, A. M., Malley, R., Saladino, R. A., Montana, J. B., MacDonald, K., & Molrine, D. C. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00399-0 · Cited by 30 · see citing works

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586 · see citing works

Development of therapeutic antibodies for the treatment of diseases

Lu, R., Hwang, Y., Liu, I.-J., Lee, C., Tsai, H.-Z., Li, H., & Wu, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,106 · see citing works

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885 · see citing works

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,649 · see citing works

Immunology of COVID-19: Current State of the Science

Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Piccoli, L., Park, Y.-J., Tortorici, M. A., Czudnochowski, N., Walls, A. C., Beltramello, M., Silacci-Fregni, C., Pinto, D., Rosen, L. E., Bowen, J. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.037 · Cited by 1,395 · see citing works

The Severe Acute Respiratory Syndrome

Peiris, J. S. M., Yuen, K., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,377 · see citing works

From SARS to MERS, Thrusting Coronaviruses into the Spotlight

Song, Z., Xu, Y., Bao, L., Zhang, L., Yü, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,268 · see citing works

Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256 · see citing works

Therapeutic potential of Toll-like receptor 9 activation

Krieg, A. Μ. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,244 · see citing works

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Tian, X., Li, C., Huang, A., Xia, S., Lu, S., Shi, Z., Lu, L., Jiang, S., Yang, Z., Wu, Y., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729069 · Cited by 1,239 · see citing works

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192 · see citing works

Coronavirus disease 2019 (COVID-19): current status and future perspectives

Li, H., Liu, S., Yu, X.-H., Tang, S., & Tang, C. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105951 · Cited by 1,174 · see citing works

Severe acute respiratory syndrome

Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,135 · see citing works

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,078 · see citing works

Assessment of the Evolution of Cancer Treatment Therapies

Arruebo, M., Vilaboa, N. E., Sáez, B., Lambea, J., Tres, A., Valladares, M., & González‐Fernández, Á. (2011) · Cancers · doi:10.3390/cancers3033279 · Cited by 932 · see citing works

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 929 · see citing works

COVID-19: what has been learned and to be learned about the novel coronavirus disease

Ye, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45134 · Cited by 836 · see citing works

Structural insights into coronavirus entry

(2019) · Advances in Virus Research · doi:10.1016/bs.aivir.2019.08.002 · Cited by 769 · see citing works

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

Stettler, K., Beltramello, M., Espinosa, D. A., Graham, V., Cassotta, A., Bianchi, S., Zatta, F., Minola, A., Jaconi, S., Mele, F., et al. (2016) · Science · doi:10.1126/science.aaf8505 · Cited by 750 · see citing works

Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species Transmission

Graham, R. L., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.01394-09 · Cited by 738 · see citing works

The promise and challenge of high-throughput sequencing of the antibody repertoire

Georgiou, G., Ippolito, G. C., Beausang, J., Busse, C. E., Wardemann, H., & Quake, S. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2782 · Cited by 652 · see citing works

From Vaccines to Memory and Back

Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 631 · see citing works

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants

ter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S.-W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030237 · Cited by 599 · see citing works

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sánchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 583 · see citing works

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Walls, A. C., Xiong, X., Park, Y.-J., Tortorici, M. A., Snijder, J., Quispe, J., Cameroni, E., Gopal, R., Dai, M., Lanzavecchia, A., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.028 · Cited by 582 · see citing works

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Walls, A. C., Fiala, B., Schäfer, A., Wrenn, S., Pham, M. N., Murphy, M., Tse, L. V., Shehata, L., O’Connor, M. A., Chen, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.043 · Cited by 532 · see citing works

Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19

Majumder, J., & Minko, T. (2021) · The AAPS Journal · doi:10.1208/s12248-020-00532-2 · Cited by 507 · see citing works

COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning

Ong, E., Wong, M. U., Huffman, A., & He, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01581 · Cited by 499 · see citing works

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

Hassan, A. O., Case, J. B., Winkler, E. S., Thackray, L. B., Kafai, N. M., Bailey, A. L., McCune, B. T., Fox, J. M., Chen, R. E., Alsoussi, W. B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.011 · Cited by 477 · see citing works

Immune response in COVID-19: A review

Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A., & Alam, A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.001 · Cited by 462 · see citing works

Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice

Murphy, A. J., Macdonald, L. E., Stevens, S. G., Karow, M. L., Dore, A. T., Pobursky, K. J., Huang, T. T., Poueymirou, W. T., Esau, L., Meola, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324022111 · Cited by 454 · see citing works

A microengraving method for rapid selection of single cells producing antigen-specific antibodies

Love, J. C., Ronan, J. L., Grotenbreg, G. M., van der Veen, A. G., & Ploegh, H. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1210 · Cited by 453 · see citing works

A novel glyco-conjugate vaccine against fungal pathogens

Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050749 · Cited by 442 · see citing works

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & Gregorio, E. D. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 438 · see citing works

Human antibodies from transgenic animals.

Lonberg, N. (2005) · Nature Biotechnology · doi:10.1038/nbt1135 · Cited by 434 · see citing works

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Zatta, F., Santos, C. P., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 433 · see citing works

Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals

Corti, D., Langedijk, J. P. M., Hinz, A., Seaman, M. S., Zatta, F., Fernandez-Rodriguez, B. M., Silacci, C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008805 · Cited by 427 · see citing works

SARS-like WIV1-CoV poised for human emergence

Menachery, V. D., Yount, B. L., Sims, A. C., Debbink, K., Agnihothram, S. S., Gralinski, L. E., Graham, R. L., Scobey, T., Plante, J. A., Royal, S. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517719113 · Cited by 418 · see citing works

High-avidity IgA protects the intestine by enchaining growing bacteria

Moor, K., Diard, M., Sellin, M. E., Felmy, B., Wotzka, S. Y., Toska, A., Bakkeren, E., Arnoldini, M., Bansept, F., Co, A. D., et al. (2017) · Nature · doi:10.1038/nature22058 · Cited by 411 · see citing works

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Case, J. B., Rothlauf, P. W., Chen, R. E., Liu, Z., Zhao, H., Kim, A. S., Bloyet, L.-M., Zeng, Q., Tahan, S., Droit, L., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.021 · Cited by 410 · see citing works

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

Kallewaard, N. L., Corti, D., Collins, P. J., Neu, U., McAuliffe, J. M., Benjamin, E., Wachter-Rosati, L., Palmer‐Hill, F. J., Yuan, A. Q., Walker, P. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.073 · Cited by 410 · see citing works

New insights into the immunopathology and control of dengue virus infection

Screaton, G. R., Mongkolsapaya, J., Yacoub, S., & Roberts, C. (2015) · Nature reviews. Immunology · doi:10.1038/nri3916 · Cited by 404 · see citing works

Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+T Cells Are Important in Control of SARS-CoV Infection

Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2009) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 400 · see citing works

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Corti, D., Misasi, J., Mulangu, S., Stanley, D. A., Kanekiyo, M., Wollen-Roberts, S. E., Ploquin, A., Doria‐Rose, N. A., Staupe, R. P., Bailey, M., et al. (2016) · Science · doi:10.1126/science.aad5224 · Cited by 398 · see citing works

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

Yu, F., Du, L., Ojcius, D. M., Pan, C., & Jiang, S. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.01.003 · Cited by 386 · see citing works

The Role of Antibodies in HIV Vaccines

Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 382 · see citing works

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.001 · Cited by 364 · see citing works

The Human Antibody Response to Dengue Virus Infection

Wahala, W. M. P. B., & de Silva, A. M. (2011) · Viruses · doi:10.3390/v3122374 · Cited by 353 · see citing works

Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex

Macagno, A., Bernasconi, N. L., Zatta, F., Dander, E., Sarasini, A., Revello, M. G., Gerna, G., Sallusto, F., & Lanzavecchia, A. (2009) · Journal of Virology · doi:10.1128/jvi.01809-09 · Cited by 326 · see citing works

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses

Kirtipal, N., Bharadwaj, S., & Kang, S. G. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104502 · Cited by 308 · see citing works

Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

Kwakkenbos, M. J., Diehl, S. A., Yasuda, E., Bakker, A. Q., van Geelen, C. M. M., Lukens, M. V., van Bleek, G. M., Widjojoatmodjo, M. N., Bogers, W. M. J. M., Mei, H. E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2071 · Cited by 297 · see citing works

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Hartley, G. E., Edwards, E. S. J., Aui, P. M., Varese, N., Stojanovic, S., McMahon, J., Peleg, A. Y., Boo, I., Drummer, H. E., Hogarth, P. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abf8891 · Cited by 296 · see citing works

Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells

Reddy, S. T., Ge, X., Miklos, A. E., Hughes, R. A., Kang, S. H., Hoi, K. H., Chrysostomou, C., Hunicke-Smith, S. P., Iverson, B. L., Tucker, P. W., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1673 · Cited by 292 · see citing works

Rapid development of broadly influenza neutralizing antibodies through redundant mutations

Pappas, L., Foglierini, M., Piccoli, L., Kallewaard, N. L., Turrini, F., Silacci, C., Fernandez-Rodriguez, B. M., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G., et al. (2014) · Nature · doi:10.1038/nature13764 · Cited by 287 · see citing works

Antibodies to combat viral infections: development strategies and progress

Pantaleo, G., Correia, B. E., Fenwick, C. W., Joo, V., & Perez, L. H. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00495-3 · Cited by 286 · see citing works

The growth and potential of human antiviral monoclonal antibody therapeutics

Marasco, W. A., & Sui, J. (2007) · Nature Biotechnology · doi:10.1038/nbt1363 · Cited by 284 · see citing works

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701000104 · Cited by 284 · see citing works

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Corti, D., Bianchi, S., Zatta, F., Minola, A., Perez, L. H., Agatic, G., Guarino, B., Silacci, C., Marcandalli, J., Marsland, B. J., et al. (2013) · Nature · doi:10.1038/nature12442 · Cited by 274 · see citing works

Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions

Li, W., Wong, S.-K., Li, F., Kuhn, J. H., Huang, I., Choe, H., & Farzan, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4211-4219.2006 · Cited by 273 · see citing works

Immunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation

Lindesmith, L. C., Beltramello, M., Donaldson, E., Corti, D., Swanstrom, J., Debbink, K. M., Lanzavecchia, A., & Baric, R. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002705 · Cited by 268 · see citing works

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2

Zhou, G., & Zhao, Q. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45123 · Cited by 262 · see citing works

A rapid and efficient single-cell manipulation method for screening antigen-specific antibody–secreting cells from human peripheral blood

Jin, A., Ozawa, T., Tajiri, K., Obata, T., Kondo, S., Kinoshita, K., Kadowaki, S., Takahashi, K., Sugiyama, T., Kishi, H., et al. (2009) · Nature Medicine · doi:10.1038/nm.1966 · Cited by 261 · see citing works

Identification of Human Single-Domain Antibodies against SARS-CoV-2

Wu, Y., Li, C., Xia, S., Tian, X., Kong, Y., Wang, Z., Gu, C., Zhang, R., Tu, C., Xie, Y., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.023 · Cited by 261 · see citing works

Changing Priorities in Vaccinology: Antibiotic Resistance Moving to the Top

Tagliabue, A., & Rappuoli, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01068 · Cited by 256 · see citing works

The Immunobiology of SARS

Chen, J., & Subbarao, K. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141706 · Cited by 252 · see citing works

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

Yang, Z., Werner, H. C., Kong, W., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 250 · see citing works

High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies

Liao, H., Levesque, M. C., Nagel, A., Dixon, A., Zhang, R., Walter, E. B., Parks, R., Whitesides, J. F., Marshall, D. J., Hwang, K., et al. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.02.014 · Cited by 249 · see citing works

Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases

Fauci, A. S., Touchette, N. A., & Folkers, G. K. (2005) · Emerging infectious diseases · doi:10.3201/eid1104.041167 · Cited by 245 · see citing works

An <i>Alphavirus</i> -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Erasmus, J. H., Khandhar, A. P., O’Connor, M. A., Walls, A. C., Hemann, E. A., Murapa, P., Archer, J., Leventhal, S., Fuller, J. T., Lewis, T. B., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc9396 · Cited by 241 · see citing works

Cellular entry of the SARS coronavirus

Hofmann, H., & Pöhlmann, S. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.08.008 · Cited by 238 · see citing works

Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies

He, Y., Lü, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 237 · see citing works

Antibody Affinity Shapes the Choice between Memory and Germinal Center B Cell Fates

Viant, C., Weymar, G. H. J., Escolano, A., Chen, S., Hartweger, H., Cipolla, M., Gazumyan, A., & Nussenzweig, M. C. (2020) · Cell · doi:10.1016/j.cell.2020.09.063 · Cited by 233 · see citing works

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

Tang, X.-C., Agnihothram, S. S., Jiao, Y., Stanhope, J., Graham, R. L., Peterson, E. C., Avnir, Y., Tallarico, A. S. C., Sheehan, J., Zhu, Q., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402074111 · Cited by 232 · see citing works

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody

Prabakaran, P., Gan, J., Feng, Y., Zhu, Z., Choudhry, V., Xiao, X., Ji, X., & Dimitrov, D. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600697200 · Cited by 232 · see citing works

Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives

Parray, H. A., Shukla, S., Samal, S., Shrivastava, T., Ahmed, S., Sharma, C., & Kumar, R. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106639 · Cited by 225 · see citing works

Clonal dissection of the human memory B‐cell repertoire following infection and vaccination

Pinna, D., Corti, D., Jarrossay, D., Sallusto, F., & Lanzavecchia, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200839129 · Cited by 222 · see citing works

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

Corti, D., Zhao, J., Pedotti, M., Simonelli, L., Agnihothram, S., Fett, C., Fernandez-Rodriguez, B., Foglierini, M., Agatic, G., Vanzetta, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510199112 · Cited by 216 · see citing works

In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection

de Alwis, R., Beltramello, M., Messer, W. B., Sukupolvi-Petty, S., Wahala, W. M. P. B., Kraus, A., Olivarez, N. P., Pham, Q., Brian, J. N., Tsai, W.-Y., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001188 · Cited by 214 · see citing works

The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody

Teoh, E. P., Kukkaro, P., Teo, E. W., Lim, A. P. C., Tan, T. T. T., Yip, A., Schul, W., Aung, M. T., Kostyuchenko, V. A., Leo, Y. S., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003888 · Cited by 214 · see citing works

A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties

Tiller, T., Schuster, I., Deppe, D., Siegers, K., Strohner, R., Herrmann, T., Berenguer, M., Poujol, D., Stehle, J., Stark, Y., et al. (2013) · mAbs · doi:10.4161/mabs.24218 · Cited by 209 · see citing works

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro

Kam, Y., Kien, F., Roberts, A., Cheung, Y. C., Lamirande, E. W., Vogel, L., Chu, S. L., Tse, J., Guarner, J., Zaki, S. R., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.08.011 · Cited by 209 · see citing works

Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza

Simmons, C. P., Bernasconi, N. L., Suguitan, A. L., Mills, K., Ward, J. M., Châu, N. V. V., Hien, T. T., Sallusto, F., Ha, D. Q., Farrar, J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040178 · Cited by 209 · see citing works

Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization

Georgiev, I. S., Doria‐Rose, N. A., Zhou, T., Kwon, Y. D., Staupe, R. P., Moquin, S. A., Chuang, G., Louder, M. K., Schmidt, S. D., Altae-Tran, H., et al. (2013) · Science · doi:10.1126/science.1233989 · Cited by 206 · see citing works

The Immune Response and Immunopathology of COVID-19

Mortaz, E., Tabarsi, P., Varahram, M., Folkerts, G., & Adcock, I. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02037 · Cited by 206 · see citing works

Single B cell technologies for monoclonal antibody discovery

Pedrioli, A., & Oxenius, A. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.10.008 · Cited by 206 · see citing works

Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly Humans

Roberts, A., Paddock, C. D., Vogel, L., Butler, E. L., Zaki, S. R., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5833-5838.2005 · Cited by 196 · see citing works

A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein

Tan, J., Sack, B. K., Oyen, D., Zenklusen, I., Piccoli, L., Barbieri, S., Foglierini, M., Fregni, C. S., Marcandalli, J., Jongo, S. A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4513 · Cited by 195 · see citing works

Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro

Chen, L., Gui, C., Luo, X., Yang, Q., Günther, S., Scandella, E., Drosten, C., Bai, D., He, X., Ludewig, B., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7095-7103.2005 · Cited by 192 · see citing works

Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors

Dhillon, A. K., Donners, H., Pantophlet, R. A., Johnson, W. E., Decker, J. M., Shaw, G. M., Lee, F.-H., Richman, D. D., Doms, R. W., Vanham, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02749-06 · Cited by 192 · see citing works

ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells

Wirths, S., & Lanzavecchia, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200535364 · Cited by 191 · see citing works

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Walls, A. C., Miranda, M. C., Schäfer, A., Pham, M. N., Greaney, A., Arunachalam, P. S., Navarro, M.-J., Tortorici, M. A., Rogers, K., O’Connor, M. A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.015 · Cited by 185 · see citing works

Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways

Rong, R., Li, B., Lynch, R. M., Haaland, R. E., Murphy, M. K., Mulenga, J., Allen, S. A., Pinter, A., Shaw, G. M., Hunter, E., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000594 · Cited by 183 · see citing works

Antibody-based therapies for malaria

Pleass, R. J., & Holder, A. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1267 · Cited by 99 · see citing works

SARS vaccines: where are we?

Roper, R. L., & Rehm, K. E. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.43 · Cited by 179 · see citing works

The global landscape of approved antibody therapies

Lyu, X., Zhao, Q., Hui, J. Y., Wang, T. L., Lin, M., Wang, K., Zhang, J., Shentu, J., Dalby, P. A., Zhang, H., et al. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac021 · Cited by 178 · see citing works

Isolation of human monoclonal antibodies by mammalian cell display

Beerli, R. R., Bauer, M., Buser, R. B., Gwerder, M., Muntwiler, S., Maurer, P., Saudan, P., & Bachmann, M. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805942105 · Cited by 175 · see citing works

Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface

Zenzo, G. D., Lullo, G. D., Corti, D., Calabresi, V., Sinistro, A., Zatta, F., Didona, B., Cianchini, G., Hertl, M., Eming, R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64413 · Cited by 174 · see citing works

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines

Salvatori, G., Luberto, L., Maffei, M., Aurisicchio, L., Roscilli, G., Palombo, F., & Marra, E. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02392-y · Cited by 174 · see citing works

Sequencing the functional antibody repertoire—diagnostic and therapeutic discovery

Robinson, W. H. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.220 · Cited by 171 · see citing works

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Wec, A. Z., Wrapp, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., et al. (2020) · Science · doi:10.1126/science.abc7424 · Cited by 520 · see citing works

Human monoclonal antibodies by immortalization of memory B cells

Lanzavecchia, A., Corti, D., & Sallusto, F. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.011 · Cited by 76 · see citing works

38227 Specific and highly potent human monoclonal antibodies against SARS-CoV-2

Barbosa, M. G. D. M., Liu, H., Huynh, D. T., Platt, J. L., & Cascalho, M. (2021) · Journal of Clinical and Translational Science · doi:10.1017/cts.2021.459

SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.

Liang, M., Du, R., Liu, J.-Z., Li, C., Zhang, Q., Han, L., Yu, J., Duan, S., Wang, X., Wu, K.-X., et al. (2005) · PubMed · Cited by 19 · see citing works

Human monoclonal antibodies and analytic vaccinology

Lanzavecchia, A. (2008) · Cancer immunity